Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Verheij

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 15, 2018
Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue SarcomasJules Lansu, Jan Groenewegen, Frits van Coevorden, et al.
Plos One|November 9, 2018
Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint associationDavid M Vossen, Caroline V M Verhagen, Reidar Grénman, et al.
The Biochemical Journal|July 29, 2011
Phosphoinositide phosphatase SHIP-1 regulates apoptosis induced by edelfosine, Fas ligation and DNA damage in mouse lymphoma cellsMaaike C Alderliesten, Jeffrey B Klarenbeek, Arnold H van der Luit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 19, 2017
Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trialsRosemarie de Haan, Dick Pluim, Baukelien van Triest, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2018
The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT)Arash Navran, Wilma Heemsbergen, Tomas Janssen, et al.
Oncotarget|May 12, 2020
Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer modelGerben R Borst, Ramya Kumareswaran, Hatice Yücel, et al.
Oncotarget|November 21, 2017
Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer modelGerben R Borst, Ramya Kumareswaran, Hatice Yücel, et al.
Oral Oncology|December 12, 2017
Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavityJoris B W Elbers, Abrahim Al-Mamgani, Danique Paping, et al.
Radiation Research|June 25, 2014
The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signalingInge Verbrugge, Alessia Gasparini, Nicole M Haynes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 6, 2006
Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusionMarina S Kartachova, Renato A Valdés Olmos, Rick L M Haas, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 15, 2018
Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue SarcomasJules Lansu, Jan Groenewegen, Frits van Coevorden, et al.
Plos One|November 9, 2018
Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint associationDavid M Vossen, Caroline V M Verhagen, Reidar Grénman, et al.
The Biochemical Journal|July 29, 2011
Phosphoinositide phosphatase SHIP-1 regulates apoptosis induced by edelfosine, Fas ligation and DNA damage in mouse lymphoma cellsMaaike C Alderliesten, Jeffrey B Klarenbeek, Arnold H van der Luit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 19, 2017
Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trialsRosemarie de Haan, Dick Pluim, Baukelien van Triest, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2018
The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT)Arash Navran, Wilma Heemsbergen, Tomas Janssen, et al.
Oncotarget|May 12, 2020
Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer modelGerben R Borst, Ramya Kumareswaran, Hatice Yücel, et al.
Oncotarget|November 21, 2017
Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer modelGerben R Borst, Ramya Kumareswaran, Hatice Yücel, et al.
Oral Oncology|December 12, 2017
Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavityJoris B W Elbers, Abrahim Al-Mamgani, Danique Paping, et al.
Radiation Research|June 25, 2014
The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signalingInge Verbrugge, Alessia Gasparini, Nicole M Haynes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 6, 2006
Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusionMarina S Kartachova, Renato A Valdés Olmos, Rick L M Haas, et al.
Pageof 19